candesartan/hct a-med 8 mg/12,5 mg tabletten
a-med gmbh - hydrochlorothiazid; candesartan cilexetil -
ramipril/amlodipin egis 10 mg/10 mg hartkapseln
egis pharmaceuticals plc. - amlodipin besilat; ramipril -
ramipril/amlodipin egis 10 mg/5 mg hartkapseln
egis pharmaceuticals plc. - amlodipin besilat; ramipril -
ramipril/amlodipin egis 5 mg/10 mg hartkapseln
egis pharmaceuticals plc. - amlodipin besilat; ramipril -
ramipril/amlodipin egis 5 mg/5 mg hartkapseln
egis pharmaceuticals plc. - amlodipin besilat; ramipril -
olmesartan g.l. 10 mg-filmtabletten
g.l. pharma gmbh - olmesartan medoxomil -
olmesartan g.l. 20 mg-filmtabletten
g.l. pharma gmbh - olmesartan medoxomil -
olmesartan g.l. 40 mg-filmtabletten
g.l. pharma gmbh - olmesartan medoxomil -
olmesartan g.l. 5 mg-filmtabletten
g.l. pharma gmbh - olmesartan medoxomil -
entresto
novartis europharm limited - sacubitril, valsartan - herzfehler - angiotensin-ii-antagonisten, andere kombinationen, mittel, die auf das renin-angiotensin-system - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.